Literature DB >> 25489269

Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child.

R Demlova1, K Melicharkova2, Z Rehak3, L Kren4, H Oslejskova5, J Sterba6.   

Abstract

BACKGROUND: Children with high-grade glioma still have a poor prognosis despite the use of multimodal therapy including surgery, radiotherapy, and chemotherapy. New therapeutic strategies and methods evaluating such therapies are needed. OBSERVATION: Here we describe a child with anaplastic oligodendroglioma of the spinal cord who was unable to tolerate standard chemoradiotherapy and who had still-vital residual tumour during therapy. A good response was obtained with low-dose metronomic treatment containing vinblastine. The treatment was guided according to gradual response assessed using various positron-emission tomography tracers.
CONCLUSIONS: Metronomic treatment guided by positron-emission tomography could be a reasonable option in some high-risk pediatric tumours.

Entities:  

Keywords:  Metronomic chemotherapy; biomarkers; pediatric glioma; pet imaging; vinblastine

Year:  2014        PMID: 25489269      PMCID: PMC4257125          DOI: 10.3747/co.21.2147

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  21 in total

1.  Metronomic chemotherapy with the COMBAT regimen in advanced pediatric malignancies: a multicenter experience.

Authors:  D Zapletalova; N André; L Deak; M Kyr; V Bajciova; P Mudry; L Dubska; R Demlova; Z Pavelka; K Zitterbart; J Skotakova; K Husek; A Martincekova; P Mazanek; T Kepak; M Doubek; L Kutnikova; D Valik; J Sterba
Journal:  Oncology       Date:  2012-04-24       Impact factor: 2.935

Review 2.  Clinical applications of PET and PET/CT in pediatric malignancies.

Authors:  Rakesh Kumar; Varun Shandal; Shamim Ahmed Shamim; Dhanapathi Halanaik; Arun Malhotra
Journal:  Expert Rev Anticancer Ther       Date:  2010-05       Impact factor: 4.512

3.  Combined biodifferentiating and antiangiogenic oral metronomic therapy is feasible and effective in relapsed solid tumors in children: single-center pilot study.

Authors:  Jaroslav Sterba; Dalibor Valik; Peter Mudry; Tomas Kepak; Zdenek Pavelka; Viera Bajciova; Karel Zitterbart; Vera Kadlecova; Pavel Mazanek
Journal:  Onkologie       Date:  2006-07-03

4.  Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity.

Authors:  G Klement; S Baruchel; J Rak; S Man; K Clark; D J Hicklin; P Bohlen; R S Kerbel
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

5.  Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.

Authors:  Eric Bouffet; Regina Jakacki; Stewart Goldman; Darren Hargrave; Cynthia Hawkins; Manohar Shroff; Juliette Hukin; Ute Bartels; Nicholas Foreman; Stewart Kellie; Joanne Hilden; Michael Etzl; Beverly Wilson; Derek Stephens; Uri Tabori; Sylvain Baruchel
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

6.  Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology.

Authors:  Eddy Pasquier; Mark W Kieran; Jaroslav Sterba; Yuval Shaked; Sylvain Baruchel; Odile Oberlin; Maria Sanna Kivivuori; Andreas Peyrl; Mamouna Diawarra; Michaela Casanova; Stergios Zacharoulis; Gilles Vassal; Franck Berthold; Arnauld Verschuur; Nicolas André
Journal:  Transl Oncol       Date:  2011-08-01       Impact factor: 4.243

7.  Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group.

Authors:  Kenneth J Cohen; Ian F Pollack; Tianni Zhou; Allen Buxton; Emiko J Holmes; Peter C Burger; Daniel J Brat; Marc K Rosenblum; Ronald L Hamilton; Robert S Lavey; Richard L Heideman
Journal:  Neuro Oncol       Date:  2011-03       Impact factor: 12.300

8.  Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.

Authors:  G Bonadonna; R Zucali; S Monfardini; M De Lena; C Uslenghi
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

Review 9.  In vivo magnetic resonance spectroscopy: basic methodology and clinical applications.

Authors:  Marinette van der Graaf
Journal:  Eur Biophys J       Date:  2009-08-13       Impact factor: 1.733

10.  18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns.

Authors:  Sanjay Chandrasekaran; Andrew Hollander; Xiangsheng Xu; Joseph L Benci; James J Davis; Jay F Dorsey; Gary Kao
Journal:  ScientificWorldJournal       Date:  2013-04-04
View more
  1 in total

1.  Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.

Authors:  Amy K Bruzek; Andrew H Zureick; Paul E McKeever; Hugh J L Garton; Patricia L Robertson; Rajen Mody; Carl J Koschmann
Journal:  Pediatr Blood Cancer       Date:  2016-11-10       Impact factor: 3.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.